Goldman Sachs Advocates Dividend Stocks and Buffer ETFs as Market Valuations Soar Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Taiwan Emerges as Defining Issue in TrumpXi Talks SpaceX Scrubs Starship Test Flight Plans Friday Attempt as V3 Debut Approaches Global Ship Lease Reports First Quarter 2026 Results Management Discusses Market Conditions and Fleet Utilization Trump Praises Palantir PLTR After Acquiring Shares Ethics Filings Reveal Recent Stock Moves BNC Q3 2023 Earnings Loss per Share of 010 as Company Continues Development Stage Operations Kadant Inc Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency IMKTA Q1 2026 Earnings Solid EPS of 128 Amid Modest Market Reaction ORIO Q1 2026 Earnings NarrowerthanExpected Loss Lifts Sentiment RILYL Q1 2024 Earnings Preferred Stock Reports Negative EPS as Market Headwinds Persist TIMB Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Persist MapLight Therapeutics Rises 24 Nearing Key Resistance Level MPLT Fortress Biotech Preferred FBIOP Gains 121 as Income Seekers Eye 9375 Yield Liberty AllStar Equity Fund Edges Higher Amid Steady Trading PLAYSTUDIOS MYPS Bounces Off Support A Closer Look at the Recent Rally Lionheart Holdings Warrant CUBWW Holds Steady at 017 Amid Narrow Trading Range SEC Delays Regulatory Exemptions for Tokenized Stock Trading ZWS Q1 2026 Earnings EPS Surges Past Estimates with 116 Beat UBX Technology Ltd UBXG Surges 84 Breaking Above Key Support Level WWW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Brand Strength High Tide Inc Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains GXAI Q1 2026 Earnings EPS Misses Estimates by 1765 Stock Declines ONON Q1 2026 Earnings EPS Smashes Estimates with 5146 Surprise Shares Edge Higher VALN Q1 2026 Earnings EPS Misses Estimates as Stock Rises Amid Operational Developments CBIO Q1 2026 Earnings Narrowed Loss Beats Expectations as Cash Management Remains Focus MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues